CLINICAL FEATURES AT ONSET AND DURING FOLLOW-UP IN PATIENTS WITH POLYCYTHEMIA VERA AND JAK2-V617F ALLELE BURDEN < 25%

被引：0
|
作者：
Di Veroli, A. [1 ]
Scalzulli, E. [2 ]
Sorrentino, A. [1 ]
Colafigli, G. [2 ]
De Gregoris, C. [1 ]
Carmosino, I. [2 ]
Fazio, S. [3 ]
Pepe, S. [2 ]
Stefanizzi, C. [1 ]
D'Errigo, M. G. [4 ]
Natalino, F. [1 ]
Ciotti, G. [2 ]
Cercola, P. [3 ]
Pessina, G. [3 ]
Mammi, C. [4 ]
Breccia, M. [2 ]
Latagliata, R. [1 ]
机构：
[1] Osped Belcolle, ASL Viterbo, UOC Ematol, Viterbo, Italy
[2] Univ Sapienza, Dipartimento Med Precis & Translaz, Policlin Umberto 1, Rome, Italy
[3] Osped Belcolle, ASL Viterbo, Lab Genet Med, Viterbo, Italy
[4] Grande Osped Metropolitano Bianchi Melacrino More, UOSD Genet Med, Reggio Di Calabria, Italy
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D108
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [31] Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera
    Liu, Dan
    Xu, Zefeng
    Zhang, Peihong
    Qin, Tiejun
    Li, Bing
    Qu, Shiqiang
    Pan, Lijuan
    Cai, Wenyu
    Liu, Jinqin
    Wang, Huijun
    Sun, Qi
    Sun, Xiujuan
    Jiao, Meng
    Gao, Qingyan
    Shi, Zhongxun
    Huang, Huijun
    Huang, Gang
    Gale, Robert Peter
    Xiao, Zhijian
    BLOOD CANCER JOURNAL, 2021, 11 (09)
  • [32] JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera
    Zhang, Sujiang
    Qiu, Hongxia
    Fischer, Bruce S.
    Li, Weida
    Duan, Limin
    Sun, Xuemei
    Xu, Wei
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 696 - 699
  • [33] Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera
    Dan Liu
    Zefeng Xu
    Peihong Zhang
    Tiejun Qin
    Bing Li
    Shiqiang Qu
    Lijuan Pan
    Wenyu Cai
    Jinqin Liu
    Huijun Wang
    Qi Sun
    Xiujuan Sun
    Meng Jiao
    Qingyan Gao
    Zhongxun Shi
    Huijun Huang
    Gang Huang
    Robert Peter Gale
    Zhijian Xiao
    Blood Cancer Journal, 11
  • [34] Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis
    Chen, Chih-Cheng
    Chen, Justin L.
    Lin, Alex Jia-Hong
    Yu, Lennex Hsueh-Lin
    Hou, Hsin-An
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 1947 - 1965
  • [35] JAK2V617F allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy
    Silver, Richard T.
    Vandris, Katherine
    Wang, Y. Lynn
    Adriano, Fernando
    Jones, Amy V.
    Christos, Paul J.
    Cross, Nicholas C. P.
    LEUKEMIA RESEARCH, 2011, 35 (02) : 177 - 182
  • [36] NATURAL EVOLUTION OF JAK2V617F ALLELE BURDEN IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PATIENTS NOT RECEIVING CYTOREDUCTIVE TREATMENT
    Besses, C.
    Alvarez-Larran, A.
    Martinez-Aviles, L.
    Longaron, R.
    Serrano, S.
    Bellosillo, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 359 - 359
  • [37] THE JAK2V617F MUTATION STATUS AND ALLELE BURDEN IN THAI PATIENTS WITH POLYCYTHEMIA VERA (PV) AND ESSENTIAL THROMBOCYTHEMIA (ET)
    Singdong, Roongrudee
    Siriboonpiputtana, Teerapong
    Kongruang, Adcharee
    Limsuwanachot, Nittaya
    Chareonsirisuthigul, Takol
    Chuncharunee, Suporn
    Sirirat, Tanasan
    Rerkamnuaychoke, Budsaba
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 98 - 98
  • [38] Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia
    Antonioli, Elisabetta
    Carobbio, Alessandra
    Pieri, Lisa
    Pancrazzi, Alessandro
    Guglielmelli, Paola
    Delaini, Federica
    Ponziani, Vanessa
    Bartalucci, Niccolo
    Tozzi, Lorenzo
    Bosi, Alberto
    Rambaldi, Alessandro
    Barbui, Tiziano
    Vannucchi, Alessandro M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1435 - 1438
  • [39] Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study
    Vannucchi, Alessandro Maria
    Verstovsek, Srdan
    Guglielmelli, Paola
    Griesshammer, Martin
    Burn, Timothy C.
    Naim, Ahmad
    Paranagama, Dilan
    Marker, Mahtab
    Gadbaw, Brian
    Kiladjian, Jean-Jacques
    ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1113 - 1120
  • [40] Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study
    Alessandro Maria Vannucchi
    Srdan Verstovsek
    Paola Guglielmelli
    Martin Griesshammer
    Timothy C. Burn
    Ahmad Naim
    Dilan Paranagama
    Mahtab Marker
    Brian Gadbaw
    Jean-Jacques Kiladjian
    Annals of Hematology, 2017, 96 : 1113 - 1120
12345